- Home
- Applications
- canada
- in vitro
Refine by
In Vitro Product Applications Available In Canada
19 applications found
Meeting the growing need for higher performing materials for medical devices, in-vitro diagnostics and pharmaceutical packaging. From our experience in multiple industries and consultation with regulatory experts, Ampacet has developed a new portfolio of medical grade masterbatch solutions. ...
ByAmpacet Corporation based in Tarrytown, NEW YORK (USA)
The expressing of this gene may then be estimated from the level of luciferase expression measured as light. This may be done in vitro, i.e. after lysing the cells adding ATP and D-luciferin, or in vivo. ...
ByBioThema AB based in Handen, SWEDEN
With Quasi Vivo, Kirkstall’s flow system, you can quickly and easily set up and run in vitro assays to detect hepatotoxicity of novel compounds. ...
ByKirkstall Ltd. based in York, UNITED KINGDOM
FluidFM® for Virology - Get a unique control over your single virion-single cell in-vitro experiment! Typically, viral infections are studied in bulk experiments where many cells in culture are exposed to the virus simultaneously, making it difficult to study single virus entry events or the spread of the viral infection between individual cells. With the gentle, micro-channeled, and force feedback-controlled FluidFM Probes, single virions can be deposited onto selected cells allowing ...
ByCytosurge AG based in Glattbrugg, SWITZERLAND
Gene synthesis refers to the artificial synthesis of double-stranded DNA molecules in vitro. At present, the required target DNA fragments are mainly obtained and amplified through gene cloning. ...
ByCD Biosciences - htDNA-chip® based in Shirley, NEW YORK (USA)
PLGA nanospheres have already been successfully used in vitro and in clinical trials. Results show that drugs encapsulated in PLGA nanoparticles have superior accumulation in the tumor environment, reduced tumor size and enhanced inhibition of cell proliferation. ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Regardless of its broad introduction across many disciplines in biology, several challenges persist in editing cell lines, particularly for sensitive cells, or when multiple edits are required. FluidFM offers a unique in-vitro gene editing tool to improve the efficiency and applicability of CRISPR across a variety of cell types and for cell line development. ...
ByCytosurge AG based in Glattbrugg, SWITZERLAND
Kirkstall’s Quasi Vivo® system aims to establish and optimise a human in vitro 3D Blood Brain Barrier (BBB) in an effort to identify important mechanistic pathways for successful biomarker analysis, drug delivery and toxicity ...
ByKirkstall Ltd. based in York, UNITED KINGDOM
Sound-induced endothelial cell condensation leads to the formation of stable vascular structures. ...
BymimiX Biotherapeutics based in Biel/Bienne, SWITZERLAND
BOC Sciences is committed to supplying cost-effective products and services. We provide Hydroxysafflor yellow A (Cas No:78281-02-4). More information, please visit the website: http://www.bocsci.com/hydroxysafflor-yellow-a-cas-78281-02-4-item-474840.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
In the era of global information, traditional storage technologies have been slightly tested. DNA must realize reliable information encoding. Only when DNA becomes a viable competitor of traditional storage technology is the first step for DNA to realize information storage. The most important thing is to produce nucleotide strings cheaply and quickly. For DNA, it is composed of four different monomers, consisting of a deoxyribonucleic acid having a skeleton with phosphoric acid. First, DNA is a polymer biological ...
ByCD Biosciences - htDNA-chip® based in Shirley, NEW YORK (USA)
BOC Sciences is committed to supplying cost-effective products and services. We provide Ceftriaxone Sodium (Cas No:74578-69-1). More information, please visit the website: http://www.bocsci.com/ceftriaxone-sodium-cas-74578-69-1-item-97893.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
With the development of society, people are becoming more and more concerned about appearance and body type. The medical beauty industry came into being and developed rapidly. The application of DNA technology in the medical beauty industry is becoming more and more common. Firstly, genetic testing related to skin conditions and obesity is more and more popular. According to the test results, the obesity type and skin condition can be known clearly, and the appearance and body shape problems can be solved in a ...
ByCD Biosciences - htDNA-chip® based in Shirley, NEW YORK (USA)
In the development of new drugs high throughput screening (HTS) is often used to screen large libraries of compounds for inhibitors or stimulators of various reactions. The firefly luciferase reaction can be performed reliably in a small reaction volume and is therefore highly suitable for HTS. Our Protein Kinase Kit RR can be used to measure not only protein kinase, but also all ATPases and aminoacyl tRNA synthetases. Growth inhibition from e.g. antibiotics can be measured. Gene expression can be monitored. ...
ByBioThema AB based in Handen, SWEDEN
In vivo evaluation of sound-patterned endothelial cells. ...
BymimiX Biotherapeutics based in Biel/Bienne, SWITZERLAND
More than 5 million people in the United States and an estimated 50 million people worldwide are living with Alzheimer’s disease. More than 10 million people worldwide are living with Parkinson’s. Brain tumors and tumors of the central nervous system are the most common form of cancer in children under 19 and the leading cause of cancer-related deaths in children under 14 in the U.S. While antibody drugs have made great strides in cancer therapies, crossing the blood-brain barrier (BBB) and ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)
As targeted therapies evolve and the limitations of antibody-based therapies become clearer, a growing number of research teams are exploring the therapeutic potential of ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)
In many therapeutic areas, current treatments involve significant side effects. Combining drug compounds with affinity agents that target specific cell surface receptors can dramatically reduce off-target effects and improve treatment effectiveness. In several studies, aptamer-mediated drug delivery has reduced toxicity and improved drug performance. ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)
Increase clinical translation with Organ-Chips for ADME-Tox assessments. Accurate ADME-Tox profiling of preclinical drug candidates remains a challenge. Preclinical ADME-Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity) studies are pivotal to predicting human response. However, approximately 30% of drugs fail during human clinical trials due to adverse reactions despite promising preclinical study results, and another 60% fail due to lack of efficacy. As companies broaden the modality toolbox ...
ByEmulate based in Boston, MASSACHUSETTS (USA)